Drug Information

Drug ID:  NPD3171
Drug Name:  
Molecular Formula:  C18H30O2
Canonical SMILES:  OCC[C@@H]1CC[C@@H]2[C@@H](C1)CC[C@]1([C@H]2CC[C@@H]1C(=O)C)C
Standard InCHI:  InChI=1S/C18H30O2/c1-12(20)16-5-6-17-15-4-3-13(8-10-19)11-14(15)7-9-18(16,17)2/h13-17,19H,3-11H2,1-2H3/t13-,14+,15+,16+,17-,18+/m0/s1
Standard InCHIKey:  OOTXTVKIKCULJJ-UIGZQWRCSA-N
Max Developmental Stage:  Clinical (unspecified phase)
Max Developmental Stage Source:  TTD

  Structural Similarity Between NPASS Natural Products and NPD3171

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.


  Similar Natural Products

High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7

Drug Structure

This browser does not support HTML5/Canvas.

External Identifiers

TTD   DIB014755
DrugBank  
ChEMBL  
IUPHAR/BPS  
PharmaGKB  
KEGG Drug  
PubChem CID   126873
ChEBI  
CAS Number  

Drug Properties

Molecular Weight  278.22
ALogP  -0.4129
MLogP  3.22
XLogP  5.075
HDA  2
HBD  1
Rotatable Bonds  6
TPSA  37.3
RO5 Violation  1